BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25383620)

  • 1. Peroxisome proliferator-activated receptor γ deficiency in T cells accelerates chronic rejection by influencing the differentiation of CD4+ T cells and alternatively activated macrophages.
    Huang X; Ren L; Ye P; Cheng C; Wu J; Wang S; Sun Y; Liu Z; Xie A; Xia J
    PLoS One; 2014; 9(11):e112953. PubMed ID: 25383620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone prevents acute and chronic cardiac allograft rejection.
    Kosuge H; Haraguchi G; Koga N; Maejima Y; Suzuki J; Isobe M
    Circulation; 2006 Jun; 113(22):2613-22. PubMed ID: 16735678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ.
    Hucke S; Floßdorf J; Grützke B; Dunay IR; Frenzel K; Jungverdorben J; Linnartz B; Mack M; Peitz M; Brüstle O; Kurts C; Klockgether T; Neumann H; Prinz M; Wiendl H; Knolle P; Klotz L
    Brain; 2012 May; 135(Pt 5):1586-605. PubMed ID: 22447120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion.
    Itoh S; Kimura N; Axtell RC; Velotta JB; Gong Y; Wang X; Kajiwara N; Nambu A; Shimura E; Adachi H; Iwakura Y; Saito H; Okumura K; Sudo K; Steinman L; Robbins RC; Nakae S; Fischbein MP
    Circulation; 2011 Sep; 124(11 Suppl):S187-96. PubMed ID: 21911812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of Smad3 improves cardiac allograft rejection in mice.
    Wang YY; Jiang H; Wang YC; Huang XR; Pan J; Yang C; Shou ZF; Xiang SL; Chen DJ; Lan HY; Chen JH
    Oncotarget; 2015 Jul; 6(19):17016-30. PubMed ID: 26219259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection.
    Zhang A; Wang K; Zhou C; Gan Z; Ma D; Ye P; Sun Y; Wu J; Huang X; Ren L; Deng P; Wu C; Yue Z; Ding X; Chen J; Xia J
    J Heart Lung Transplant; 2017 Feb; 36(2):175-184. PubMed ID: 27296836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Necroptosis Is Involved in CD4+ T Cell-Mediated Microvascular Endothelial Cell Death and Chronic Cardiac Allograft Rejection.
    Kwok C; Pavlosky A; Lian D; Jiang J; Huang X; Yin Z; Liu W; Haig A; Jevnikar AM; Zhang ZX
    Transplantation; 2017 Sep; 101(9):2026-2037. PubMed ID: 29633982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double deficiency for RORγt and T-bet drives Th2-mediated allograft rejection in mice.
    Sabet-Baktach M; Eggenhofer E; Rovira J; Renner P; Lantow M; Farkas SA; Malaisé M; Edtinger K; Shaotang Z; Koehl GE; Dahlke MH; Schlitt HJ; Geissler EK; Kroemer A
    J Immunol; 2013 Oct; 191(8):4440-6. PubMed ID: 24058178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cannabinoid receptor 2 is involved in acute rejection of cardiac allografts.
    Kemter AM; Scheu S; Hüser N; Ruland C; Schumak B; Findeiß M; Cheng Z; Assfalg V; Arolt V; Zimmer A; Alferink J
    Life Sci; 2015 Oct; 138():29-34. PubMed ID: 25744392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-γ agonists prevent in vivo remodeling of human artery induced by alloreactive T cells.
    Tobiasova Z; Zhang L; Yi T; Qin L; Manes TD; Kulkarni S; Lorber MI; Rodriguez FC; Choi JM; Tellides G; Pober JS; Kawikova I; Bothwell AL
    Circulation; 2011 Jul; 124(2):196-205. PubMed ID: 21690493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR5 blockade in combination with cyclosporine increased cardiac graft survival and generated alternatively activated macrophages in primates.
    Li J; Chen G; Ye P; Wang S; Zhang K; Chen W; Stepkowski SM; Li J; Zhong S; Xia J
    J Immunol; 2011 Mar; 186(6):3753-61. PubMed ID: 21307294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of macrophage-dependent peroxisome proliferator-activated receptor γ signalling on adhesion formation after abdominal surgery in an experimental model.
    Hong GS; Schwandt T; Stein K; Schneiker B; Kummer MP; Heneka MT; Kitamura K; Kalff JC; Wehner S
    Br J Surg; 2015 Nov; 102(12):1506-16. PubMed ID: 26313905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex-Based Selectivity of PPARγ Regulation in Th1, Th2, and Th17 Differentiation.
    Park HJ; Park HS; Lee JU; Bothwell AL; Choi JM
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin attenuates acute cardiac allograft rejection by antagonizing RORγt activity.
    Wu J; Zhou C; Chen W; Xie A; Li J; Wang S; Ye P; Wang W; Xia J
    Transplantation; 2013 Feb; 95(3):434-41. PubMed ID: 23296151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of parathyroid graft rejection suggests alloantigen-specific production of nitric oxide by iNOS-positive intragraft macrophages.
    Matuschek A; Ulbrich M; Timm S; Schneider M; Thomas Germer C; Ulrichs K; Otto C
    Transpl Immunol; 2009 Sep; 21(4):183-91. PubMed ID: 19409993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-L1/PD-1 signal deficiency promotes allogeneic immune responses and accelerates heart allograft rejection.
    Wang W; Carper K; Malone F; Latchman Y; Perkins J; Fu Y; Reyes J; Li W
    Transplantation; 2008 Sep; 86(6):836-44. PubMed ID: 18813109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged allograft survival in anti-CD4 antibody transgenic mice: lack of residual helper T cells compared with other CD4-deficient mice.
    Han WR; Zhan Y; Murray-Segal LJ; Brady JL; Lew AM; Mottram PL
    Transplantation; 2000 Jul; 70(1):168-74. PubMed ID: 10919596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
    Xia G; He J; Zhang Z; Leventhal JR
    Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.
    Chan SY; DeBruyne LA; Goodman RE; Eichwald EJ; Bishop DK
    Transplantation; 1995 Apr; 59(8):1155-61. PubMed ID: 7732563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.